"Despite emerging attention, the personalized medicine received recent years, many pharmaceutical and economical challenges still awaits resolution before personal medicine settles. In this study we try to address some of the economic challenges when a new gene-based medicine comes to practice."

This is the question Hossein present, along with a theoretical model that studies the implementation and financing system of the new revolutionary gene-based medicine.